29 Aug, 2022 CereVasc Announces First Patient Treated in U.S. Pilot Trial Evaluating the eShunt System in Patients with Normal Pressure Hydrocephalus Admin2023-11-06T21:52:45+00:00August 29th, 2022| Read More
09 Aug, 2022 CereVasc Announces FDA Approval of Second IDE Study of the eShunt® System Admin2023-11-06T21:48:30+00:00August 9th, 2022| Read More
